Abstract

Lipocalin 2 (LCN2) is a highly conserved secreted adipokine acting as a serum transport protein for small hydrophobic molecules such as fatty acids and steroids. In addition, LCN2 limits bacterial growth by sequestering iron-containing siderophores and further protects against intestinal inflammation and tumorigenesis associated with alterations in the microbiota. Human LCN2 contains one N-glycosylation site conserved in other species. It was postulated that this post-translational modification could facilitate protein folding, protects from proteolysis, is required for proper trafficking from the Golgi apparatus to the cell surface, and might be relevant for effective secretion. We here show that the homologous nucleoside antibiotic tunicamycin blocks N-linked glycosylation but not secretion of LCN2 in primary murine hepatocytes, derivatives thereof, human lung carcinoma cell line A549, and human prostate cancer cell line PC-3. Moreover, both the glycosylated and the non-glycosylated LCN2 variants are equally targeted to exosomes, demonstrating that this post-translational modification is not necessary for proper trafficking of LCN2 into these membranous extracellular vesicles. Furthermore, a hydrophobic cluster analysis revealed that the N-glycosylation site is embedded in a highly hydrophobic evolutionarily conserved surrounding. In sum, our data indicate that the N-glycosylation of LCN2 is not required for proper secretion and exosome cargo recruitment in different cell types, but might be relevant to increase overall solubility.

Highlights

  • In humans, ∼15% of all genes are predicted to have at least one secreted protein product1

  • We have previously shown that the Lipocalin 2 (LCN2) expression dramatically increases in vivo in response to damage, inflammation, and in primary isolated hepatocytes cultured for prolonged times (Borkham-Kamphorst et al, 2011, 2013; Labbus et al, 2013; Asimakopoulou et al, 2016a)

  • In livers obtained from mice intraperitoneally injected with Lipopolysaccharide (LPS) for 6 h, neutrophils significantly increasing in number are most prominently immunopositive for LCN2 (Figure 1A)

Read more

Summary

Introduction

In humans, ∼15% of all genes are predicted to have at least one secreted protein product1 These proteins form the human protein secretome having important cellular and systemic functions in immune defense, intercellular communication, cell adhesion, cell differentiation, morphogenesis, and angiogenesis (Hathout, 2007). Molecules involved in the innate and adaptive immune response are modulated by N-glycosylation (Rudd et al, 2001) This posttranslational modification contributes to the stability of the protein, enhances folding efficiency, prevents aggregation, facilitates formation of proper disulfide bonds, helps to orient binding forces, and provides protease protection. This is illustrated in the biological consequences resulting from alterations within a single N-glycosylation site of the prostatespecific antigen (PSA) leading to prostate cancer development or faster disease progression (Drake et al, 2015)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.